Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
25.45B | 23.83B | 21.53B | 18.06B | 17.27B | Gross Profit |
13.55B | 12.34B | 10.87B | 9.46B | 9.27B | EBIT |
5.85B | 4.83B | 3.62B | 3.76B | 2.81B | EBITDA |
10.16B | 12.17B | 10.16B | 9.84B | 8.49B | Net Income Common Stockholders |
3.15B | 2.84B | 1.67B | 2.96B | 1.83B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.69B | 5.04B | 4.74B | 9.80B | 4.65B | Total Assets |
56.33B | 55.26B | 56.41B | 49.82B | 41.65B | Total Debt |
15.61B | 16.03B | 17.80B | 12.91B | 10.72B | Net Debt |
12.35B | 12.95B | 15.25B | 7.68B | 8.15B | Total Liabilities |
29.92B | 29.24B | 31.01B | 24.71B | 18.47B | Stockholders Equity |
26.40B | 26.02B | 25.40B | 25.11B | 23.18B |
Cash Flow | Free Cash Flow | |||
7.78B | 7.92B | 4.70B | 4.79B | 4.78B | Operating Cash Flow |
12.33B | 12.42B | 9.43B | 12.76B | 8.67B | Investing Cash Flow |
-4.95B | -4.68B | -8.62B | -9.37B | -5.29B | Financing Cash Flow |
-7.20B | -7.21B | -3.49B | -735.37M | -3.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $7.44B | 12.72 | 12.04% | 3.52% | -0.91% | 1.51% | |
77 Outperform | $13.93B | 13.70 | 7.95% | 2.68% | -0.47% | 1.69% | |
76 Outperform | $8.63B | 9.72 | 11.19% | 4.98% | -2.34% | 12.31% | |
75 Outperform | $5.34B | 11.92 | 6.76% | 2.55% | 8.78% | -21.85% | |
70 Outperform | $8.55B | 25.87 | 3.02% | 5.79% | -3.60% | -51.54% | |
64 Neutral | $27.79B | ― | <0.01% | 4.83% | 1.18% | ― | |
58 Neutral | $12.88B | 6.77 | -2.53% | 3.86% | 2.36% | -36.74% |